2021

Meet a New ASP Member: Dr. Jie Li

January 6, 2022 by ASP Newsletter

Jie Li in his microbial culture room. PHOTO: Dan Xue Dr. Jie Li is our featured new member in this issue of the Newsletter. Dr. Li started his independent career as an assistant professor in the Department of Chemistry and…

HOT TOPICS IN PHARMACOGNOSY: Revisions of “Repurposing for CoV-2” and Potential Uses of Cationic Peptide Compounds as Antibiotics and Other Diseases

October 22, 2021 by ASP Newsletter

David J. Newman, DPhil REPURPOSING FOR COV-2 In the February 2021 ASP Newsletter I commented on and gave “potted precises” of the work done on large scale repurposing of known drugs in order to try to “short-circuit” the time required…

Inaugural ASP Vanguards Virtual Symposium Series a Great Success!

October 11, 2021 by ASP Newsletter

By C. Benjamin Naman, PhD and Karen VanderMolen, PhD As we collectively surpass a year and a half together in the global COVID-19 pandemic, many of us suffer from online meeting fatigue and sore monitor eyes. The ASP overcame these…

ASP President McPhail Addresses Members

October 8, 2021 by ASP Newsletter

Dr. Kerry McPhail PHOTO: DANIEL SEEMILLER By Kerry McPhail, PhD NOTE: A video of President McPhail’s address to members at the July 28th ASP Business Meeting is available at www.pharmacognosy.us/presidential-remarks-asp-business-meeting-2021/ I am profoundly moved and honored to have this opportunity…

HOT TOPICS IN PHARMACOGNOSY: So What About the Other Half of Kinase Inhibitor Activities?

July 12, 2021 by ASP Newsletter

By David J. Newman, DPhil INTRODUCTION Although we have been inundated over the years with stories of the successes with inhibiting protein tyrosine kinases (aka PTKs) and their chemical cousins, based on other amino acids such as serine or threonine…